DCM
LKFT

DME Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

DME Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Hold
482,746
– – 0.37% 41
2026
Q1 		$14.5M Hold
482,746
– – 0.45% 37
2025
Q4 		$15.8M Hold
482,746
– – 0.55% 30
2025
Q3 		$16.7M Hold
482,746
– – 0.66% 23
2025
Q2 		$13.5M Hold
482,746
– – 0.58% 23
2025
Q1 		$12.1M Buy
482,746
+3,383
+0.7% +$85.5K 0.61% 21
2024
Q4 		$13.2M Hold
479,363
– – 0.68% 21
2024
Q3 		$13.8M Buy
479,363
+244,535
+104% +$6.66M 0.57% 26
2024
Q2 		$5.82M Buy
234,828
+75,000
+47% +$2.13M 0.28% 26
2024
Q1 		$5.15M Buy
+159,828
New +$5.94M 0.24% 28

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DME Capital Management's LKFT Position: Q2 2026 in Review

DME Capital Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q2 2026 at 482,746 shares worth $14.5M. The position accounts for 0.37% of the portfolio, ranked #41.

DME Capital Management first reported a position in LKFT in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.7M in Q3 2025. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • DME Capital Management held 482,746 shares of Lakefront Biotherapeutics American Depositary Shares worth $14.5M as of Q2 2026.
  • DME Capital Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.37% of DME Capital Management's portfolio in Q2 2026, its #41 holding.
  • DME Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2024 and has held it in 10 quarters since.
  • DME Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $16.7M in Q3 2025.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.